DK0991479T3 - Pakningsenhed til indgivelse til lugteområdet - Google Patents

Pakningsenhed til indgivelse til lugteområdet

Info

Publication number
DK0991479T3
DK0991479T3 DK98930657T DK98930657T DK0991479T3 DK 0991479 T3 DK0991479 T3 DK 0991479T3 DK 98930657 T DK98930657 T DK 98930657T DK 98930657 T DK98930657 T DK 98930657T DK 0991479 T3 DK0991479 T3 DK 0991479T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical preparation
administration
packing unit
olfactory
human
Prior art date
Application number
DK98930657T
Other languages
Danish (da)
English (en)
Inventor
Gizurarson Sveinbjoern
Original Assignee
Lyfjathroun Biopharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36699744&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0991479(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lyfjathroun Biopharmaceuticals filed Critical Lyfjathroun Biopharmaceuticals
Application granted granted Critical
Publication of DK0991479T3 publication Critical patent/DK0991479T3/da

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
    • B05B11/00—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use
    • B05B11/01—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use characterised by the means producing the flow
    • B05B11/02—Membranes or pistons acting on the contents inside the container, e.g. follower pistons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
    • B05B1/00—Nozzles, spray heads or other outlets, with or without auxiliary devices such as valves, heating means
    • B05B1/02—Nozzles, spray heads or other outlets, with or without auxiliary devices such as valves, heating means designed to produce a jet, spray, or other discharge of particular shape or nature, e.g. in single drops, or having an outlet of particular shape
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
    • B05B11/00—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use
    • B05B11/0005—Components or details
    • B05B11/0027—Means for neutralising the actuation of the sprayer ; Means for preventing access to the sprayer actuation means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/08—Inhaling devices inserted into the nose
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/70—Nanostructure
    • Y10S977/788—Of specified organic or carbon-based composition
    • Y10S977/797—Lipid particle
    • Y10S977/798—Lipid particle having internalized material
    • Y10S977/799—Containing biological material
    • Y10S977/801—Drug
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
DK98930657T 1997-07-01 1998-07-01 Pakningsenhed til indgivelse til lugteområdet DK0991479T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IS4516A IS4516A (is) 1997-07-01 1997-07-01 Nýtt lyfjaform

Publications (1)

Publication Number Publication Date
DK0991479T3 true DK0991479T3 (da) 2006-03-13

Family

ID=36699744

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98930657T DK0991479T3 (da) 1997-07-01 1998-07-01 Pakningsenhed til indgivelse til lugteområdet

Country Status (10)

Country Link
US (1) US6647980B1 (US06647980-20031118-M00002.png)
EP (1) EP0991479B1 (US06647980-20031118-M00002.png)
AT (1) ATE307676T1 (US06647980-20031118-M00002.png)
AU (1) AU739893B2 (US06647980-20031118-M00002.png)
CA (1) CA2298596A1 (US06647980-20031118-M00002.png)
DE (1) DE69832070T2 (US06647980-20031118-M00002.png)
DK (1) DK0991479T3 (US06647980-20031118-M00002.png)
ES (1) ES2255165T3 (US06647980-20031118-M00002.png)
IS (1) IS4516A (US06647980-20031118-M00002.png)
WO (1) WO1999001229A1 (US06647980-20031118-M00002.png)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7033598B2 (en) 1996-11-19 2006-04-25 Intrabrain International N.V. Methods and apparatus for enhanced and controlled delivery of a biologically active agent into the central nervous system of a mammal
DE10004547A1 (de) * 2000-02-02 2001-08-09 Liedtke Pharmed Gmbh Verfahren zur selektiven Verabreichung zentralnervös aktiver Stoffe
US6853858B2 (en) * 2000-05-08 2005-02-08 Brainsgate, Ltd. Administration of anti-inflammatory drugs into the central nervous system
DE60219442T2 (de) * 2001-02-08 2007-08-16 Nasaleze Patents Ltd., Ramsey Gerät zur ausgabe von pulverförmigem material
EP1521599A2 (en) * 2002-02-25 2005-04-13 Lyfjathroun HF, Biopharmaceutical Research Absorption enhancing agent
PT1501576E (pt) 2002-05-09 2010-03-29 Glaxo Group Ltd Dispositivo de distribuição de fluido
US20040039352A1 (en) * 2002-06-28 2004-02-26 Paul Bergeson Nasal dosing device
JP2007501252A (ja) * 2003-08-05 2007-01-25 スリーエム イノベイティブ プロパティズ カンパニー 免疫応答調整剤を含有する製剤
GB0405477D0 (en) 2004-03-11 2004-04-21 Glaxo Group Ltd A fluid dispensing device
PL1699512T3 (pl) 2003-11-03 2012-11-30 Glaxo Group Ltd Urządzenie do dozowania płynów
US20060207596A1 (en) * 2005-03-18 2006-09-21 Fairfield Clinical Trials, Llc Device and method for delivery of combination nasal medication
GB0507224D0 (en) 2005-04-09 2005-05-18 Glaxo Group Ltd A fluid dispensing device
WO2007064657A1 (en) * 2005-11-29 2007-06-07 Alza Corporation Nasal delivery device for the delivery of a substance to the olfactory region
EP1984049A1 (en) * 2006-01-19 2008-10-29 Optinose AS Nasal administration
GB0604444D0 (en) 2006-03-06 2006-04-12 Optinose As Nasal devices
GB2438834A (en) * 2006-06-08 2007-12-12 Optinose As Intranasal protein administration
US20080228162A1 (en) * 2007-03-16 2008-09-18 Medlmmune Vaccines, Inc. Single-use ampoule
GB2448193A (en) 2007-04-05 2008-10-08 Optinose As Nasal delivery device
WO2008137632A1 (en) * 2007-05-04 2008-11-13 The Procter & Gamble Company Antimicrobial compositions, products, and methods of use
JP2011511674A (ja) * 2008-02-07 2011-04-14 ユニヴァーシティ オブ ワシントン 周方向エアロゾルデバイス
RU2485982C1 (ru) 2009-05-19 2013-06-27 Эдуард Н. ЛЕРНЕР Устройство и способы улучшенной многократной доставки биологически активных веществ внутрь организма и для предотвращения местного раздражения
RU2612506C2 (ru) 2011-03-03 2017-03-09 Импел Ньюрофарма Инк. Устройство для назальной доставки лекарственных средств
CA2835208C (en) 2011-05-09 2019-08-20 Impel Neuropharma, Inc. Nozzles for nasal drug delivery
US10537692B2 (en) 2013-04-28 2020-01-21 Impel Neuropharma, Inc. Medical unit dose container
GB201308679D0 (en) 2013-05-14 2013-06-26 3M Innovative Properties Co Actuator for an inhaler
MA42708A (fr) 2015-09-10 2018-07-04 Impel Neuropharma Inc Dispositif d'administration nasale en ligne
CA3081680A1 (en) 2017-11-21 2019-05-31 Impel Neuropharma, Inc. Intranasal device with inlet interface
US11571532B2 (en) 2017-11-21 2023-02-07 Impel Pharmaceuticals Inc. Intranasal device with dip tube
CN111836615A (zh) 2018-01-05 2020-10-27 英倍尔药业股份有限公司 通过精密鼻装置的奥氮平的鼻内递送
ES2937440T3 (es) 2018-01-05 2023-03-28 Impel Pharmaceuticals Inc Administración intranasal de dihidroergotamina mediante un dispositivo olfativo de precisión
KR20210034047A (ko) 2018-07-19 2021-03-29 임펠 뉴로파마 인코포레이티드 파킨슨 병 치료를 위한 레보도파 및 도파 데카르복실라아제 저해제의 기도 전달
JP7213991B2 (ja) 2019-01-03 2023-01-27 インペル ファーマシューティカルズ インコーポレイテッド 経鼻薬送達器具
KR20220010011A (ko) 2019-05-17 2022-01-25 임펠 뉴로파마 인코포레이티드 일회용 비강 전달 장치
EP4028085A4 (en) * 2019-09-13 2023-10-04 Janssen Pharmaceuticals, Inc. INTRANASAL ADMINISTRATION OF ESKETAMINE
FR3120534B1 (fr) * 2021-03-09 2023-06-30 Aptar France Sas Tête de distribution nasale de produit fluide et dispositif comportant une telle tête

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4054622A (en) * 1970-11-03 1977-10-18 Lester Victor E Combination nebulizer and humidifier
US3762409A (en) * 1970-11-03 1973-10-02 V Lester Nebulizer
CH539556A (de) * 1971-03-16 1973-07-31 Ciba Geigy Ag Applikator zur dosierten Ausgabe einer Flüssigkeit
US3961756A (en) * 1975-02-10 1976-06-08 National Chemsearch Corporation Adjustable-spray mechanism
US4961727A (en) * 1988-11-16 1990-10-09 Beard Walter C Dispensing package
US5116315A (en) * 1989-10-03 1992-05-26 Hemaedics, Inc. Biological syringe system
CA2070823C (en) 1989-12-05 1999-01-12 William H. Ii Frey Neurologic agents for nasal administration to the brain
DE4016126A1 (de) * 1990-04-17 1991-10-24 Coster Tecnologie Speciali Spa Vorrichtung zur transnasalen oder oralen verabreichung von medikamenten o. dgl.
WO1993002729A1 (en) * 1990-07-12 1993-02-18 Habley Medical Technology Corporation Super atomizing nonchlorinated fluorocarbon medication inhaler
DK198591D0 (da) * 1991-12-10 1991-12-10 Novo Nordisk As Apparat
US5525329A (en) 1992-05-21 1996-06-11 The Johns Hopkins University Inhibition of phosphodiesterase in olfactory mucosa
GB9405952D0 (en) * 1994-03-25 1994-05-11 Zeneca Ltd Aqueous ophthalmic sprays
FR2732318B1 (fr) * 1995-03-31 1997-04-25 Oreal Ditributeur aerosol a deux buses de pulverisation
GB9519692D0 (en) * 1995-09-27 1995-11-29 Quillin Helen Atomising nozzle
WO1997016181A1 (en) 1995-11-03 1997-05-09 University Of Kentucky Method for the intranasal administration of l-dopa prodrugs
US5921233A (en) * 1997-09-04 1999-07-13 Pincgold Llc Liquid dispenser assembly particularly for medical applications

Also Published As

Publication number Publication date
CA2298596A1 (en) 1999-01-14
DE69832070T2 (de) 2006-07-13
IS4516A (is) 1999-01-02
EP0991479B1 (en) 2005-10-26
WO1999001229A1 (en) 1999-01-14
US6647980B1 (en) 2003-11-18
AU739893B2 (en) 2001-10-25
ATE307676T1 (de) 2005-11-15
AU8102298A (en) 1999-01-25
DE69832070D1 (de) 2005-12-01
EP0991479A1 (en) 2000-04-12
ES2255165T3 (es) 2006-06-16

Similar Documents

Publication Publication Date Title
DK0991479T3 (da) Pakningsenhed til indgivelse til lugteområdet
SE9703191D0 (sv) Medicament for improvement of duration of muscle function or treatment of muscle disorders or diseases
GEP20043216B (en) Orally Administered Controlled Drug Delivery System
BR0108730A (pt) Sistema, dispositivo e método para administração de uma droga, bocal de um dispositivo de administração de droga, dispositivo para administração de doses unitárias múltiplas de uma droga, métodos para preparação de um sistema de administração de droga e de uma formulação de droga e para tratamento de um paciente que necessita de doses múltiplas de uma droga, formulação de droga e multiparticulados
DE69518334D1 (de) Pharmazeutische aerosol welche mindestens ein zucker enthält
ATE292982T1 (de) Analgesiche synergie durch gleichzeitige verabreichung von subanalgesichen doseneines mu- opioidanagonisten und eines kappa - 2- opioidanagonisten
UA88270C2 (ru) Фармацевтический препарат и его применение для профилактики удара, диабета
DE69527842D1 (de) Oral anzuwendendes flüssiges arzneimittel enthaltend alendronat
ES2162615T3 (es) Metodo para tratar o prevenir diabetes de tipo 1 mediante la administracion oral de insulina.
NL990012I1 (nl) Geneesmiddelen die salmeterol en fluticason bevatten.
ES2171469T3 (es) Composicion administrada por via nasal y preparacion que la contiene.
ATE234602T1 (de) Verabreichungsform zur abgabe von steigenden wirkstoffdosen
DE69306379T2 (de) Inhalierbare arzneimittel
NO925038D0 (no) Anordning for nedsettelse av medikamentets hudirriterendevirkninger
BR9802537A (pt) Método para anestesiar um paciente humano antes de cirurgias de porte dose unitária e sistema farmacêutico para administração
NO890186L (no) Fremgangsmaate for fremstilling av en avgivelses- og/ellerdoseringsform for legemiddelaktive stoffer.
TNSN01003A1 (fr) Appareil d'administration d'aerosols a comptage de dose dans des propulseurs hydrofluoroalcanes.
DE69200711D1 (de) Pharmazeutische Zusammensetzungen enthaltend Fluticasonpropionat und Oxikonazol oder dessen Salz zur lokalen Anwendung.
WO1999020244A3 (de) Verfahren zur transdermalen applikation von wirkstoffen in hoher, konstanter dosierung
KR930019224A (ko) 유산 위험 치료제
IL164317A0 (en) Statin therapy for enhancing cognitive maintenance
EP1690531A3 (en) Dosage form and method for administering drug
TH66360A3 (th) องค์ประกอบและวิธีการเกี่ยวกับการรักษาโรคภูมิแพ้
RU97116821A (ru) Способ лечения респираторных заболеваний
KR910005856A (ko) 호흡기 질환 치료용 제약 조성물